PGGM Investments’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8M Hold
62,273
0.61% 49
2026
Q1
$28.7M Hold
62,273
0.5% 60
2025
Q4
$35.3M Hold
62,273
0.56% 55
2025
Q3
$27.9M Buy
62,273
+10,848
+21% +$5.21M 0.45% 57
2025
Q2
$27.9M Buy
51,425
+46,632
+973% +$24.4M 0.48% 58
2025
Q1
$2.37M Buy
4,793
+2,832
+144% +$1.57M 0.03% 261
2024
Q4
$1.02M Buy
1,961
+1,715
+697% +$893K 0.01% 302
2024
Q3
$121K Buy
+246
New +$115K ﹤0.01% 348
2023
Q4
Sell
-2,476
Closed -$724K 356
2023
Q3
$724K Buy
2,476
+954
+63% +$298K 0.01% 312
2023
Q2
$520K Buy
+1,522
New +$461K 0.01% 329
2016
Q2
Sell
-33,804
Closed -$2.26M 381
2016
Q1
$2.26M Sell
33,804
-237,357
-88% -$14.7M 0.01% 381
2015
Q4
$16.5M Sell
271,161
-2,970
-1% -$167K 0.09% 253
2015
Q3
$14M Sell
274,131
-3,591
-1% -$203K 0.08% 263
2015
Q2
$15M Sell
277,722
-14,553
-5% -$814K 0.08% 273
2015
Q1
$16.4M Buy
+292,275
New +$16.5M 0.08% 290

Other funds holding ISRG

PGGM Investments's ISRG Position: Q2 2026 in Review

PGGM Investments held its Intuitive Surgical (ISRG) position steady in Q2 2026 at 62,273 shares worth $24.8M. The position accounts for 0.61% of the portfolio, ranked #49.

PGGM Investments first reported a position in ISRG in Q1 2015 and has held it in 15 quarters since. The position peaked at $35.3M in Q4 2025. 2,232 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • PGGM Investments held 62,273 shares of Intuitive Surgical worth $24.8M as of Q2 2026.
  • PGGM Investments left its Intuitive Surgical share count unchanged in Q2 2026.
  • Intuitive Surgical made up 0.61% of PGGM Investments's portfolio in Q2 2026, its #49 holding.
  • PGGM Investments first reported a position in Intuitive Surgical in Q1 2015 and has held it in 15 quarters since.
  • PGGM Investments's Intuitive Surgical position peaked at $35.3M in Q4 2025.
  • 2,232 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on PGGM Investments's 13F filing for Q2 2026, filed 12 Aug 2026.